Lv1
30 积分 2025-07-23 加入
Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial
1天前
已完结
Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review
1天前
已完结
Development and Evaluation of the Efficacy of a Phage Cocktail Against Pseudomonas aeruginosa
1个月前
已完结
Advancing bacteriophages as a treatment of antibiotic-resistant bacterial pulmonary infections
1个月前
已完结
Bacteriophage therapy in clinical practice: case studies of Pseudomonas aeruginosa infections
1个月前
已完结
Scrutinizing apicomplexans
2个月前
已完结
Guidelines to Compose an Ideal Bacteriophage Cocktail
4个月前
已完结
[Treatment of infectious bronchial asthma and other respiratory tract diseases with bacteriophages]
4个月前
已关闭
Bacteriophages for bronchiectasis: treatment of the future?
4个月前
已完结
NLRP3 Inflammasome Activation Modulates Neutrophil Extracellular Trap Formation and Aggravates Airway Inflammation in Bronchiectasis
5个月前
已完结
皖公网安备34019202002308
